144 related articles for article (PubMed ID: 36326418)
21. [Relationship between CD4⁺CD25(High)CD127(low) regularly T cells in the peripheral blood and tumor regression after neoadjuvant therapy in patients with rectal cancer].
Wang H; Liu H; Su W; Zhang Y; Feng Y; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Apr; 18(4):361-4. PubMed ID: 25940180
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte nadir predicts tumor response and survival in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Immunologic relevance.
Liu H; Wang H; Wu J; Wang Y; Zhao L; Li G; Zhou M
Radiother Oncol; 2019 Feb; 131():52-59. PubMed ID: 30773187
[TBL] [Abstract][Full Text] [Related]
23. Tumor Microenvironment Mediators CD8
Zaghloul H; Abbas A; Abdulah D
J Gastrointest Cancer; 2021 Mar; 52(1):177-186. PubMed ID: 32112202
[TBL] [Abstract][Full Text] [Related]
24. Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer.
Huang Y; Lou XY; Zhu YX; Wang YC; Zhang L; Liu HL; Wang C; Zhan HM; Cheng ZQ; Tan WY; Wang L; Fan XJ
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30867256
[TBL] [Abstract][Full Text] [Related]
25. Implication of programmed cell death ligand 1 expression in tumor recurrence and prognosis in rectal cancer with neoadjuvant chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Inoue Y; Mori K; Ide S; Imaoka H; Kawamura M; Mohri Y; Kusunoki M
Int J Clin Oncol; 2016 Oct; 21(5):946-952. PubMed ID: 26919982
[TBL] [Abstract][Full Text] [Related]
26. Preoperative oral immunonutrition in gastrointestinal surgical patients: How the tumour microenvironment can be modified.
D'Ignazio A; Kabata P; Ambrosio MR; Polom K; Marano L; Spagnoli L; Ongaro A; Pieretti L; Marrelli D; Biviano I; Roviello F
Clin Nutr ESPEN; 2020 Aug; 38():153-159. PubMed ID: 32690150
[TBL] [Abstract][Full Text] [Related]
27. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer].
Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667
[No Abstract] [Full Text] [Related]
28. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.
Preston CC; Maurer MJ; Oberg AL; Visscher DW; Kalli KR; Hartmann LC; Goode EL; Knutson KL
PLoS One; 2013; 8(11):e80063. PubMed ID: 24244610
[TBL] [Abstract][Full Text] [Related]
29. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.
He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C
Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005
[TBL] [Abstract][Full Text] [Related]
30. Perioperative Immunonutrition Modulates Inflammatory Response after Radical Cystectomy: Results of a Pilot Randomized Controlled Clinical Trial.
Hamilton-Reeves JM; Stanley A; Bechtel MD; Yankee TM; Chalise P; Hand LK; Lee EK; Smelser W; Mirza M; Wyre H; Hull H; Carlson SE; Holzbeierlein JM
J Urol; 2018 Aug; 200(2):292-301. PubMed ID: 29518432
[TBL] [Abstract][Full Text] [Related]
31. Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8
Lim YJ; Koh J; Kim S; Jeon SR; Chie EK; Kim K; Kang GH; Han SW; Kim TY; Jeong SY; Park KJ; Wu HG
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1216-1224. PubMed ID: 29165286
[TBL] [Abstract][Full Text] [Related]
32. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
33. A radiomic signature model to predict the chemoradiation-induced alteration in tumor-infiltrating CD8
Jeon SH; Lim YJ; Koh J; Chang WI; Kim S; Kim K; Chie EK
Radiother Oncol; 2021 Sep; 162():124-131. PubMed ID: 34265357
[TBL] [Abstract][Full Text] [Related]
34. Impact of Immunonutrition on T Cell Activation: A Randomized Control Study in Cardiac Surgery Patients.
Svetikienė M; Trybė D; Strioga M; Vėželienė J; Isajevas V; Malickaitė R; Jurgauskienė L; Ringaitienė D; Šerpytis M; Šipylaitė J
Acta Med Litu; 2021; 28(2):240-252. PubMed ID: 35637935
[TBL] [Abstract][Full Text] [Related]
35. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemoradiotherapy of pancreatic cancer induces a favorable immunogenic tumor microenvironment associated with increased major histocompatibility complex class I-related chain A/B expression.
Murakami T; Homma Y; Matsuyama R; Mori R; Miyake K; Tanaka Y; Den K; Nagashima Y; Nakazawa M; Hiroshima Y; Ueda M; Tanaka K; Hoffman RM; Bouvet M; Endo I
J Surg Oncol; 2017 Sep; 116(3):416-426. PubMed ID: 28608409
[TBL] [Abstract][Full Text] [Related]
37. Tumor-Infiltrating PD-1+ Immune Cell Density is Associated with Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
Kitagawa Y; Akiyoshi T; Yamamoto N; Mukai T; Hiyoshi Y; Yamaguchi T; Nagasaki T; Fukunaga Y; Hirota T; Noda T; Kawachi H
Clin Colorectal Cancer; 2022 Mar; 21(1):e1-e11. PubMed ID: 35123891
[TBL] [Abstract][Full Text] [Related]
38. Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma.
Shamseddine A; Zeidan YH; Kreidieh M; Khalifeh I; Turfa R; Kattan J; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Khoury C; El Husseini Z; Charafeddine M; Al Darazi M; Geara F
BMC Cancer; 2020 Sep; 20(1):831. PubMed ID: 32873251
[TBL] [Abstract][Full Text] [Related]
39. Pre-Operative Immunonutrition Enhances Postoperative Outcomes and Elevates Tumor-Infiltrating Lymphocyte Counts in Colorectal Cancer Patients: A Meta-Analysis of Randomized Controlled Trials.
Zhang M; Chen G; Jin X; Wang J; Yu S
Nutr Cancer; 2024; 76(6):499-512. PubMed ID: 38655678
[TBL] [Abstract][Full Text] [Related]
40. [Changes in the CD8+ Density of Tumor Infiltrating Lymphocytes after Neoadjuvant Radiochemotherapy in Patients with Rectal Adenocarcinom].
Buka D; Dvořák J; Sitorová V; Hátlová J; Richter I; Sirák I
Klin Onkol; 2016; 29(3):204-9. PubMed ID: 27296405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
